 |
|
Stomach cancer rate set to fall further 25 percent over next decade
August 14, 2007Epidemiological trends of premalignant gastric lesions: A long-term nationwide study in the Netherlands
New cases of stomach cancer are set to plummet a further 25 per cent in the West over the next decade, indicates research published ahead of print in the journal Gut.
Stomach cancer is the fourth most common cancer, and the second leading cause of cancer related death, in the world.
The findings are based on the long term monitoring of the three types of cell changes indicative of subsequent stomach cancer.
The authors tracked all new cases of atrophic gastritis, intestinal metaplasia, and dysplasia recorded in the Dutch national registry of diseased tissue samples.
The monitoring period covered the years 1991 to 2005 and included almost 98,000 patients who had a routine tissue sample (biopsy) taken.
Most of the cases were intestinal metaplasia, which was diagnosed in almost 66,000 patients during the monitoring period.
The figures showed that the rate of new cases fell steadily by between 2.4 and 2.9% a year in women and men, respectively.
Dysplasia, which was diagnosed in just over 8500 patients, and atrophic gastritis, which was diagnosed in just over 23,000, both fell by more than 8% a year.
The fall in new cases of intestinal metaplasia and atrophic gastritis was even sharper after 1996, the figures showed.
On the basis of these trends, the authors calculate that new cases of gastric cancer will fall by "at least 24%" over the next decade in the West, without the need for treatment.
The authors say that the fall in the number of cases of gastric inflammation caused by Helicobacter pylori infection largely explains the figures.
BMJ-British Medical Journal
The findings are based on the long term monitoring of the three types of cell changes indicative of subsequent stomach cancer.
The authors tracked all new cases of atrophic gastritis, intestinal metaplasia, and dysplasia recorded in the Dutch national registry of diseased tissue samples.
The monitoring period covered the years 1991 to 2005 and included almost 98,000 patients who had a routine tissue sample (biopsy) taken.
Most of the cases were intestinal metaplasia, which was diagnosed in almost 66,000 patients during the monitoring period.
The figures showed that the rate of new cases fell steadily by between 2.4 and 2.9% a year in women and men, respectively.
Dysplasia, which was diagnosed in just over 8500 patients, and atrophic gastritis, which was diagnosed in just over 23,000, both fell by more than 8% a year.
The fall in new cases of intestinal metaplasia and atrophic gastritis was even sharper after 1996, the figures showed.
On the basis of these trends, the authors calculate that new cases of gastric cancer will fall by "at least 24%" over the next decade in the West, without the need for treatment.
The authors say that the fall in the number of cases of gastric inflammation caused by Helicobacter pylori infection largely explains the figures.
BMJ-British Medical Journal
Stomach Cancer News and Current Stomach Cancer Events RSSGoing from ulcers to cancer
Researchers have uncovered a big clue as to why some of the bacteria that cause stomach ulcers pose a greater risk for serious problems like stomach cancer than others; it turns out these bacteria can exploit the surrounding stomach cells to protect them from the immune system.
New research from Rhode Island Hospital may help predict outcomes for stomach cancer patients
Researchers at Rhode Island Hospital have identified two potential molecular markers that may predict outcomes for patients with stomach cancer, one of the most common and fatal cancers worldwide.
OHSU Cancer Institute researchers find many stomach cancer patients are not gertting best therapy
New findings from Oregon Health & Science University Cancer Institute show significant numbers of patients nationwide who are not getting the recommended therapy after surgery to remove stomach cancer.
Early treatment of stomach infection may prevent cancer
Based on research using a new mouse model of gastritis and stomach cancer, researchers from the Massachusetts Institute of Technology (MIT) say that prompt treatment of Helicobacter pylori (H. pylori) infections reverses damage to the lining of the stomach that can lead to cancer.
Stomach stem cell discovery could bring cancer insights
Scientists have identified and described stem cells specific to several tissues and organs of the body - key master cells that give rise to the specialized cell types characteristic of that organ.
Researchers identify cell pathway in colon cancer
For the one in 18 men and women who will be diagnosed with cancer of the colon and rectum during their lifetime and over 150,000 people diagnosed on a yearly basis, today's genetic research news offers some optimism.
Researchers identify cell pathway in colon cancer
For the one in 18 men and women who will be diagnosed with cancer of the colon and rectum during their lifetime and over 150,000 people diagnosed on a yearly basis, today's genetic research news offers some optimism.
Researcher hits bulls-eye for antibiotic target
A Purdue University researcher has opened the door for possible antibiotic treatments for a variety of diseases by determining the structure of a protein that controls the starvation response of E. coli.
Basic work on E. coli identifies two new keys to regulation of bacterial gene expression
The cellular process of transcription, in which the enzyme RNA polymerase constructs chains of RNA from information contained in DNA, depends upon previously underappreciated sections of both the DNA promoter region and RNA polymerase, according to work done with the bacterium E. coli.
Mayo Clinic studies find association between acid reflux and esophageal cancer
Two new Mayo Clinic studies draw attention to the risk factors and possible genetic basis for Barrett's esophagus and esophageal cancer (adenocarcinoma).
More Stomach Cancer News Articles
 | Not Fade Away: A Short Life Well Lived by Laurence Shames, Peter Barton Some people are born to lead and destined to teach by the example of living life to the fullest, and facing death with uncommon honesty and courage. Peter Barton was that kind of person. Driven by the ideals that sparked a generation, he became an overachieving Everyman, a risk-taker who showed others what was possible. Then, in the prime of his life — hugely successful, happily married, and... |
 | Breast Cancer and Iodine : How to Prevent and How to Survive Breast Cancer by Dr. David Derry M.D., Ph.D. This book is about cause, prevention and treatment of breast cancer. Breast cancer has two phases. The first one, from abnormal cells up to carcinoma in situ reverses with iodine. The second phase, invasion, is controlled by connective tissue thyroid... |
 | 100 Q&A About Gastric Cancer (100 Questions & Answers about . . .) (100 Questions and Answers) by Manish A. Shah About 21,700 Americans are diagnosed with stomach cancer each year and it occurs most often in people in their 60s and 70s. Whether you're a newly diagnosed patient with gastric cancer or a friend or relative of someone with cancer, this book offers help. This book is an invaluable resource for anyone coping with the physical and emotional turmoil of this disease. The author Dr. Shah is from... |
 | Healing Lessons by Sidney Winawer Dr. Sidney Winawer, chief of gastroenterology at Memorial Sloan-Kettering Cancer Center in New York City, thought he was being paged. "Winawer. Winawer," a voice called. But it wasn't the hospital's paging system that was beckoning him; it was an intake nurse, calling to admit his wife, Andrea, for her surgery for metastatic stomach cancer. While Winawer had treated thousands of cancer patients... |
 | An Energetic Approach to Oncology (Chinese Medical Qigong Therapy, Volume 5) The information contained within the Chinese Medical Qigong Therapy: A Comprehensive Clinical Text has currently been tripled, and formatted into five exciting new textbooks. The five new Medical Qigong textbooks are composed of both modern and ancient knowledge, graphics and expanded techniques guaranteed to fascinate and intrigue the reader. Never before in the history of Chinese Medicine has a... |
 | The Diversity of Gastric Carcinoma: Pathogenesis, Diagnosis and Therapy Japan has long been a leader of research into the carcinogenesis, pathology, diagnosis, and treatment of gastric carcinoma, which is still the second leading cause of cancer death worldwide. Distinguished experts in the field collaborated in creating this groundbreaking work, providing a comprehensive view of gastric cancer. This book encourages further development of gastric cancer research and... |
| Management of Gastric Cancer (Cancer Treatment and Research) | |
| Gale Encyclopedia of Medicine: Stomach cancer by Bob Kirsch PhD The article is excerpted from Gale Encyclopedia of Medicine. Consult the second edition of this authoritative, comprehensive, in-depth medical guide for information on more than 1,700 medical topics in language accessible to adult laypersons. Presented in a single alphabetical sequence, articles range in length from one or two paragraphs for minor topics, to several pages or more for major... | |
| End-results in the treatment of gastric cancer;: An analytical study and statistical survey of sixty years of surgical treatment, by Edward Meakin Livingston | |
| Ulcer-cancer of the stomach(carcinoma ex ulcere ventriculi) (Glasgow. University. Publications series;no 99) by Matthew John Stewart |
| © 2008 BrightSurf.com |